The frequency of CD127(low) expressing CD4(+)CD25(high) T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis


Autoria(s): MICHAELSSON, Jakob; BARBOSA, Hugo Marcelo R.; JORDAN, Kimberley A.; CHAPMAN, Joan M.; BRUNIALTI, Milena K. C.; KLEINE NETO, Walter; NUKUI, Youko; SABINO, Ester C.; CHIEIA, Marco Antonio; OILIVEIRA, Acary Souza Bulle; NIXON, Douglas F.; KALLAS, Esper G.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

18/04/2012

18/04/2012

2008

Resumo

Background: CD4(+)CD25(high) regulatory T (T(Reg)) cells modulate antigen-specific T cell responses, and can suppress anti-viral immunity. In HTLV-1 infection, a selective decrease in the function of T(Reg) cell mediated HTLV-1-tax inhibition of FOXP3 expression has been described. The purpose of this study was to assess the frequency and phenotype of T(Reg) cells in HTLV-1 asymptomatic carriers and in HTLV-1-associated neurological disease (HAM/TSP) patients, and to correlate with measures of T cell activation. Results: We were able to confirm that HTLV-1 drives activation, spontaneous IFN gamma production, and proliferation of CD4+ T cells. We also observed a significantly lower proportion of CTLA-4(+) T(Reg) cells (CD4(+)CD25(high) T cells) in subjects with HAM/TSP patients compared to healthy controls. Ki-67 expression was negatively correlated to the frequency of CTLA-4(+) T(Reg) cells in HAM/TSP only, although Ki-67 expression was inversely correlated with the percentage of CD127(low) T(Reg) cells in healthy control subjects. Finally, the proportion of CD127(low) T(Reg) cells correlated inversely with HTLV-1 proviral load. Conclusion: Taken together, the results suggest that T(Reg) cells may be subverted in HAM/TSP patients, which could explain the marked cellular activation, spontaneous cytokine production, and proliferation of CD4(+) T cells, in particular those expressing the CD25(high)CD127(low) phenotype. T(Reg) cells represent a potential target for therapeutic intervention for patients with HTLV-1-related neurological diseases.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)[04/10918-6]

NIH[A141531]

NIH[A152731]

NIH[A1060379]

NIH[A1064520]

(NIH) The Fogarty International Center[D43 TW00003]

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Brazilian Ministry of Education

Identificador

BMC IMMUNOLOGY, v.9, 2008

1471-2172

http://producao.usp.br/handle/BDPI/15094

10.1186/1471-2172-9-41

http://dx.doi.org/10.1186/1471-2172-9-41

Idioma(s)

eng

Publicador

BIOMED CENTRAL LTD

Relação

BMC Immunology

Direitos

openAccess

Copyright BIOMED CENTRAL LTD

Palavras-Chave #I-ASSOCIATED MYELOPATHY #KAPPA-B SITE #TAX PROTEIN #CYTOKINE PRODUCTION #CD4+CD25+T CELLS #GENE-EXPRESSION #SELF-TOLERANCE #INFECTED-CELLS #BLOOD-DONORS #ANTIGEN 4 #Immunology
Tipo

article

original article

publishedVersion